Journal of Vaccine Research 2024, Vol.14, No.6, 297-306 http://medscipublisher.com/index.php/jvr 301 4.3 Cellular immune enhancement technology New delivery platforms are revolutionizing the efficiency of antigen presentation. The nanoparticle vaccine administered through the nasal cavity can precisely target the respiratory tract mucosa and significantly enhance the activity of CD4 T cells in the lungs by optimizing antigen presentation (Nelson et al., 2021). Its modular design allows for flexible adjustment of the intensity of immune stimulation. Recombinant adenovirus (rAd) vectors have performed outstandingly in nasal vaccines. The conserved influenza proteins they carry can induce potent and long-lasting T-cell immunity in the respiratory tract. This local immune enhancement is crucial for establishing a long-term protective barrier (Misplon et al., 2023). 5 T-Cell Immunity: Comprehensive Defense and Strategic Implications 5.1 Cross-reactive immune mechanisms T lymphocytes demonstrate essential antiviral capabilities through their ability to target evolutionarily stable viral elements. Both CD4+ helper cells and CD8+ cytotoxic cells recognize conserved protein regions, establishing defense networks against diverse influenza variants. Experimental models and human studies reveal that vaccine-induced robust T-cell activation confers multi-strain protection. CD4+ cells exhibit dual functionality by facilitating antibody generation and enhancing CD8+ memory formation (Valkenburg et al., 2018). This protective capacity was evident during the 2009 pandemic, where subjects with vigorous T-cell responses experienced reduced viral replication and attenuated symptom severity (Sridhar, 2016). Notably, animal studies confirm that T-cell vaccines induce heterosubtypic immunity—a critical attribute for broad-spectrum protection. Airway-resident memory T-cells demonstrate particular effectiveness against antigenically distinct viral strains through rapid response activation (Schmidt and Lapuente, 2021). These findings position T-cell-mediated immunity as fundamental to developing pan-influenza vaccines (Clemens et al., 2018). 5.2 Optimizing benefits while mitigating challenges While promising, T-cell-targeted vaccination strategies require careful optimization. Influenza's capacity for immune evasion through epitope mutation presents ongoing efficacy concerns. Individual genetic variability in HLA molecules further complicates population-wide vaccine effectiveness. Additionally, dysregulated T-cell activity may paradoxically exacerbate pulmonary inflammation during infection, underscoring the necessity of balancing viral clearance with immunopathological control. Comprehensive safety evaluations remain imperative, particularly regarding cytokine dysregulation risks (Li et al., 2014; Clemens et al., 2018; Lo et al., 2021). 5.3 Long-term immunological memory development The durability of T-cell-mediated protection constitutes a major vaccine advantage. Emerging data indicate adenoviral vector vaccines sustain polyvalent immune responses (both humoral and cellular) for extended periods exceeding 12 months. Strategic focus on inducing airway tissue-resident memory cells enables accelerated secondary responses. Prime-boost regimens amplify cross-protective capacity, though achieving persistent immunity requires precise characterization of memory T-cell biomarkers, functional parameters, and maintenance pathways. Contemporary investigations seek to elucidate these determinants, aiming to transcend conventional seasonal vaccine limitations (Clemens et al., 2018; Lo et al., 2021; Schmidt and Lapuente, 2021). 6 T lymphocyte Immune Assessment System 6.1 Key technologies for activity detection Modern immunosurveillance mainly relies on two core methods: enzyme-linked immunospot assay (ELISpot) and multi-parameter flow cytometry. In the clinical study of the FLU-v vaccine, the dual-channel ELISpot system successfully captured the proliferation signals of specific immune cells after vaccination by simultaneously detecting interferon -γ and granzyme B secreting cells (Oftung et al., 2022). This technology can not only identify the release of single cytokines, but also analyze the complex immune response pattern. Flow cytometry provides a multi-dimensional perspective for the functional analysis of T cells. The Savic’s (2016) study employed ten-color fluorescence labeling technology to systematically reveal the killing efficacy and
RkJQdWJsaXNoZXIy MjQ4ODYzNQ==